Drug
Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Pemphigus | 345 | 935.4 | 2,028.1 | signal |
| 2 | Hand Deformity | 305 | 782.1 | 1,493.3 | signal |
| 3 | Helicobacter Infection | 192 | 628.9 | 898.1 | signal |
| 4 | Pericarditis | 289 | 578.3 | 1,053.6 | signal |
| 5 | Synovitis | 257 | 473.3 | 790.3 | signal |
| 6 | Glossodynia | 309 | 459.2 | 887.0 | signal |
| 7 | Folliculitis | 121 | 388.3 | 478.6 | signal |
| 8 | Wound | 295 | 351.4 | 651.0 | signal |
| 9 | Autoimmune Disorder | 94 | 324.9 | 380.7 | signal |
| 10 | Systemic Lupus Erythematosus | 335 | 313.2 | 656.2 | signal |
| 11 | Hypercholesterolaemia | 73 | 251.9 | 284.2 | signal |
| 12 | Wound Infection | 80 | 242.9 | 277.5 | signal |
| 13 | Contraindicated Product Administered | 218 | 238.5 | 361.2 | signal |
| 14 | Bursitis | 71 | 193.9 | 218.0 | signal |
| 15 | Liver Injury | 140 | 190.8 | 243.9 | signal |
| 16 | Joint Range Of Motion Decreased | 76 | 187.3 | 212.5 | signal |
| 17 | Prescribed Overdose | 105 | 178.7 | 213.6 | signal |
| 18 | Fibromyalgia | 127 | 172.2 | 214.6 | signal |
| 19 | Arthropathy | 277 | 163.5 | 287.5 | signal |
| 20 | Laryngitis | 52 | 157.7 | 171.5 | signal |
| 21 | Hip Arthroplasty | 72 | 156.1 | 175.7 | signal |
| 22 | Type 2 Diabetes Mellitus | 159 | 155.0 | 205.9 | signal |
| 23 | Red Blood Cell Sedimentation Rate Increased | 52 | 154.3 | 167.9 | signal |
| 24 | Irritable Bowel Syndrome | 99 | 152.5 | 180.2 | signal |
| 25 | Lower Limb Fracture | 87 | 149.9 | 173.4 | signal |
| 26 | Discomfort | 262 | 142.2 | 240.1 | signal |
| 27 | Sciatica | 68 | 141.1 | 157.7 | signal |
| 28 | Prescribed Underdose | 82 | 135.2 | 155.0 | signal |
| 29 | Infusion Related Reaction | 262 | 130.5 | 220.2 | signal |
| 30 | Foot Deformity | 43 | 127.4 | 136.5 | signal |
| 31 | Pulmonary Fibrosis | 74 | 127.3 | 143.9 | signal |
| 32 | Maternal Exposure During Pregnancy | 316 | 117.8 | 231.7 | signal |
| 33 | Therapeutic Product Effect Decreased | 159 | 117.8 | 156.4 | signal |
| 34 | Psoriatic Arthropathy | 143 | 116.9 | 150.3 | signal |
| 35 | Hepatic Enzyme Increased | 234 | 113.2 | 177.9 | signal |
| 36 | Knee Arthroplasty | 71 | 111.9 | 125.8 | signal |
| 37 | Joint Dislocation | 35 | 109.3 | 115.5 | signal |
| 38 | Obesity | 52 | 107.1 | 116.5 | signal |
| 39 | Impaired Healing | 106 | 106.1 | 127.0 | signal |
| 40 | Swelling | 291 | 102.4 | 187.0 | signal |
| 41 | Blood Cholesterol Increased | 145 | 102.2 | 131.8 | signal |
| 42 | Rheumatoid Arthritis | 340 | 98.8 | 209.7 | signal |
| 43 | Gait Inability | 99 | 98.3 | 116.1 | signal |
| 44 | Drug Intolerance | 271 | 92.5 | 159.7 | signal |
| 45 | Blister | 149 | 87.4 | 113.6 | signal |
| 46 | Treatment Failure | 216 | 86.4 | 130.0 | signal |
| 47 | Hepatic Cirrhosis | 49 | 86.1 | 93.2 | signal |
| 48 | Incorrect Route Of Product Administration | 43 | 84.0 | 90.0 | signal |
| 49 | Joint Stiffness | 56 | 70.1 | 76.7 | signal |
| 50 | Joint Swelling | 253 | 69.0 | 113.4 | signal |
| 51 | Abdominal Discomfort | 348 | 68.4 | 148.6 | signal |
| 52 | Oedema | 110 | 66.7 | 80.3 | signal |
| 53 | Night Sweats | 65 | 66.3 | 73.7 | signal |
| 54 | Osteoarthritis | 84 | 64.9 | 74.6 | signal |
| 55 | Ear Pain | 38 | 64.1 | 68.1 | signal |
| 56 | Lower Respiratory Tract Infection | 88 | 63.7 | 73.7 | signal |
| 57 | Injury | 136 | 63.2 | 80.0 | signal |
| 58 | Delirium | 64 | 60.8 | 67.4 | signal |
| 59 | Road Traffic Accident | 76 | 59.6 | 67.5 | signal |
| 60 | Musculoskeletal Stiffness | 159 | 59.5 | 78.9 | signal |
| 61 | Ear Infection | 48 | 59.4 | 64.1 | signal |
| 62 | Epilepsy | 55 | 59.2 | 64.6 | signal |
| 63 | Stomatitis | 108 | 58.4 | 70.1 | signal |
| 64 | Wheezing | 104 | 57.7 | 68.7 | signal |
| 65 | Mobility Decreased | 125 | 57.3 | 70.9 | signal |
| 66 | Disability | 34 | 56.4 | 59.5 | signal |
| 67 | Therapy Non-responder | 76 | 56.0 | 63.4 | signal |
| 68 | Alopecia | 329 | 54.9 | 111.9 | signal |
| 69 | C-reactive Protein Increased | 59 | 53.2 | 58.5 | signal |
| 70 | Taste Disorder | 31 | 50.8 | 53.3 | signal |
| 71 | Intentional Product Use Issue | 134 | 50.0 | 63.0 | signal |
| 72 | Liver Function Test Increased | 30 | 46.1 | 48.4 | signal |
| 73 | Hypersensitivity | 258 | 45.7 | 75.8 | signal |
| 74 | Pregnancy | 27 | 43.8 | 45.7 | signal |
| 75 | Back Injury | 14 | 42.4 | 43.3 | signal |
| 76 | Muscle Spasticity | 16 | 42.3 | 43.4 | signal |
| 77 | Musculoskeletal Pain | 66 | 41.0 | 45.6 | signal |
| 78 | Exposure During Pregnancy | 76 | 40.1 | 45.4 | signal |
| 79 | Liver Disorder | 54 | 40.0 | 43.6 | signal |
| 80 | General Physical Health Deterioration | 140 | 40.0 | 50.9 | signal |
| 81 | Inflammation | 62 | 39.6 | 43.8 | signal |
| 82 | Lung Disorder | 59 | 39.5 | 43.4 | signal |
| 83 | Drug-induced Liver Injury | 34 | 36.2 | 38.1 | signal |
| 84 | Sleep Disorder | 77 | 36.1 | 40.9 | signal |
| 85 | Respiratory Disorder | 32 | 35.0 | 36.8 | signal |
| 86 | Gastrointestinal Disorder | 93 | 34.5 | 40.2 | signal |
| 87 | Ill-defined Disorder | 63 | 34.0 | 37.6 | signal |
| 88 | Adverse Event | 95 | 33.8 | 39.5 | signal |
| 89 | Product Use Issue | 192 | 33.7 | 47.7 | signal |
| 90 | Dry Mouth | 81 | 32.8 | 37.4 | signal |
| 91 | Loss Of Personal Independence In Daily Activities | 47 | 32.4 | 34.9 | signal |
| 92 | Sinusitis | 100 | 31.9 | 37.6 | signal |
| 93 | Upper Respiratory Tract Infection | 44 | 31.3 | 33.5 | signal |
| 94 | Osteoporosis | 39 | 31.1 | 33.0 | signal |
| 95 | Hypoaesthesia | 141 | 30.9 | 39.3 | signal |
| 96 | Dyspepsia | 92 | 30.8 | 35.7 | signal |
| 97 | Migraine | 88 | 30.4 | 35.1 | signal |
| 98 | Adverse Drug Reaction | 81 | 29.7 | 33.8 | signal |
| 99 | Asthma | 101 | 29.5 | 34.9 | signal |
| 100 | Contusion | 84 | 28.7 | 32.8 | signal |
| 101 | Amnesia | 57 | 28.6 | 31.3 | signal |
| 102 | Sleep Disorder Due To A General Medical Condition | 14 | 28.4 | 29.0 | signal |
| 103 | Infection | 118 | 26.8 | 32.7 | signal |
| 104 | Urticaria | 124 | 24.4 | 30.1 | signal |
| 105 | Peripheral Swelling | 106 | 22.6 | 26.9 | signal |
| 106 | Immunodeficiency | 10 | 22.3 | 22.6 | signal |
| 107 | Rash | 289 | 21.9 | 39.0 | signal |
| 108 | Drug Hypersensitivity | 128 | 21.6 | 26.8 | signal |
| 109 | Nasopharyngitis | 120 | 21.3 | 26.0 | signal |
| 110 | Condition Aggravated | 190 | 20.6 | 28.9 | signal |
| 111 | Hypertension | 133 | 20.6 | 25.7 | signal |
| 112 | Muscular Weakness | 70 | 20.2 | 22.5 | signal |
| 113 | Coeliac Disease | 6 | 20.0 | 20.2 | signal |
| 114 | Therapeutic Product Effect Incomplete | 43 | 19.9 | 21.3 | signal |
| 115 | Confusional State | 98 | 19.8 | 23.3 | signal |
| 116 | Adrenal Insufficiency | 7 | 19.2 | 19.4 | signal |
| 117 | Product Use In Unapproved Indication | 142 | 19.1 | 24.2 | signal |
| 118 | Pain | 343 | 18.3 | 38.2 | signal |
| 119 | Bronchitis | 41 | 18.1 | 19.2 | signal |
| 120 | Arthritis | 42 | 17.5 | 18.6 | signal |
| 121 | Abdominal Pain Upper | 105 | 16.8 | 19.8 | signal |
| 122 | Memory Impairment | 70 | 16.7 | 18.6 | signal |
| 123 | Weight Increased | 110 | 16.2 | 19.3 | signal |
| 124 | Colitis Ulcerative | 22 | 16.2 | 16.7 | signal |
| 125 | Medication Error | 27 | 15.9 | 16.6 | signal |
| 126 | Gait Disturbance | 93 | 15.9 | 18.4 | signal |
| 127 | Therapeutic Response Decreased | 28 | 15.2 | 15.9 | signal |
| 128 | Paraesthesia | 71 | 14.8 | 16.5 | signal |
| 129 | Visual Impairment | 53 | 14.1 | 15.3 | signal |
| 130 | Arthralgia | 165 | 13.1 | 17.2 | signal |
| 131 | Inflammatory Bowel Disease | 3 | 10.0 | 10.0 | signal |
| 132 | Underdose | 21 | 9.4 | 9.7 | signal |
| 133 | Psoriasis | 37 | 9.3 | 9.8 | signal |
| 134 | Product Quality Issue | 25 | 6.1 | 6.3 | signal |